Inhibikase Therapeutics, Inc.
Recent Filings
All 330 filings →| Form | Description | Date |
|---|---|---|
| S-8 | S-8 | Mar 26, 2026 |
| 10-K | 10-K | Mar 26, 2026 |
| 8-K | 8-K | Mar 26, 2026 |
| 4 | 4 | Feb 24, 2026 |
| 4 | 4 | Feb 24, 2026 |
| 4 | 4 | Feb 24, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 13, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| SANDS FRANK M. | — | Purchase | 2,068,965 @ $1.45 | 13,018,965 | Nov 21, 2025 |
| Munshi Amit | — | Award / Grant | 57,265 | 57,265 | Feb 21, 2025 |
| Bellini Roberto | — | Purchase | 1,460,000 @ $1.37 | 1,460,000 | Oct 21, 2024 |
| Kush Arvind | — | Purchase | 145,000 @ $1.37 | 145,000 | Oct 21, 2024 |
| Munshi Amit | — | Purchase | 365,000 @ $1.37 | 365,000 | Oct 21, 2024 |
| Werner Milton H. | President and CEO | Purchase | 5,000 @ $0.80 | 5,335,433 | Aug 16, 2022 |
| Werner Milton H. | President and CEO | Purchase | 5,000 @ $0.98 | 5,330,433 | May 27, 2022 |
| Werner Milton H. | President and CEO | Purchase | 10,000 @ $0.60 | 5,325,433 | May 20, 2022 |
| FRATTAROLI JOSEPH | Chief Financial Officer | Purchase | 3,948 @ $0.64 | 48,091 | May 19, 2022 |
| Werner Milton H. | President and CEO | Purchase | 1,100 @ $1.97 | 23,589 | Nov 17, 2021 |